Advion has recently revealed that its expression compact mass spectrometer is compatible with Agilent Technologies’ HPLC and UHPLC systems.
A Japanese research group recently published data on a new method for determining D-serine, a protein which could be used as a biomarker for measuring effects new drugs have on the central nervous system, in a mouse brain.
System targets personalized medicine for biomarker discovery and predicting drug efficacy.
World’s largest clinical trial in pre- and early diabetes utilizes Myriad RBM’s biomarker technology.
PharmaDiagnostics’ assay product range and development strategy is set to benefit with the acquisition of a former pharma department head to the executive team.